The Japanese manufacturer has agreed to purchase its cell culture technology from Kyoto Seisakusho. This company has developed a system that limits cell damage and allows culturing up to 10 times more cells in a single pass than conventional equipment. This reduces the number of test cycles that need to be done each time and lowers costs.

Regenerative medicine deals with the restoration of damaged tissue through the activation of endogenous stem cells or cell transplantation. For example, it can help in the treatment of cancer.

Source: Ferra

Previous articleVirtuix Launches Affordable VR Gaming Platform Omni One
Next articleConnect Apple Pencil 1 to an unsupported iPad Air or iPad Pro
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.

LEAVE A REPLY

Please enter your comment!
Please enter your name here